Decisions about pharmaceuticals, medicine shortages, medical devices or clinical trials.
3 decisions this term since 23 Oct 2024 · 3 adopted, 0 rejected · 2 A vote in which every MEP’s individual position is recorded and published.
Climate & environment, Resolution, 18 Jun 2026
Motion for a resolution
Adopted 294 for · 245 against · 28 abstained by a small majority
AI summary:It supports the directive's environmental goals but worries that higher-than-expected costs and the polluter-pays scheme could hurt medicine availability and EU manufacturing.
Economy & single market, New EU law, 20 Jan 2026
Report by Tomislav Sokol · Parliament’s first vote on a proposed EU law. It sets Parliament’s position for negotiations with the Council.
Passed 503 for · 57 against · 108 abstained by a large majority
AI summary:The position also calls for better use of existing data tools and involvement of stakeholders across the supply chain.
Economy & single market, Resolution, 23 Oct 2024
Motion for a resolution
Adopted Decided by show of hands: no count recorded.
AI summary:The revision should address implementation challenges, consider stakeholders' views, and focus on timely availability of medical technologies, a more predictable system, and less administrative burden for manufacturers.
How each group voted in the last 2 final A vote in which every MEP’s individual position is recorded and published.. For / Against / Abstained: at least two thirds of the group voted that way. Divided: no position had two thirds of the group’s votes. On the winning side: how many of those votes ended the way most of the group voted. Groups as they are now.
The laws and files behind these decisions, most recent vote first.
Last voted on 18 Jun 2026
Last voted on 20 Jan 2026
Last voted on 23 Oct 2024